EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Humacyte, Inc. (HUMA) had EBIT Margin of -5845.45% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.49M |
|
$-17.62M |
|
$2.04M |
|
$-1.54M |
|
$29.43M |
|
$-28.93M |
|
$11.32M |
|
$-17.62M |
|
$-17.62M |
|
$-17.62M |
|
$-17.62M |
|
$-17.62M |
|
$-17.62M |
|
$-28.93M |
|
$-26.86M |
|
197.85M |
|
197.85M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$63.60M |
|
$17.38M |
|
$46.96M |
|
$110.56M |
|
$16.19M |
|
$63.47M |
|
$82.75M |
|
$98.93M |
|
$11.62M |
|
$11.62M |
|
$11.62M |
|
222.02M |
|
| Cash Flow Statement Financials | |
$-25.10M |
|
$-0.17M |
|
$23.32M |
|
$50.85M |
|
$48.89M |
|
$-1.96M |
|
$3.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.93 |
|
-- |
|
-- |
|
0.85 |
|
5.67 |
|
-311.72% |
|
-5845.45% |
|
|
EBIT Margin |
-5845.45% |
-- |
|
-3559.39% |
|
-3559.39% |
|
$-25.28M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.21 |
|
1.14 |
|
78.91 |
|
-151.57% |
|
-151.57% |
|
-15.94% |
|
-23.46% |
|
$0.05 |
|
$-0.13 |
|
$-0.13 |
|